160 related articles for article (PubMed ID: 22855160)
1. Reduced expression of Raf kinase inhibitor protein correlates with poor prognosis in pancreatic cancer.
Song SP; Zhang SB; Li ZH; Zhou YS; Li B; Bian ZW; Liao QD; Zhang YD
Clin Transl Oncol; 2012 Nov; 14(11):848-52. PubMed ID: 22855160
[TBL] [Abstract][Full Text] [Related]
2. Loss of Raf-1 kinase inhibitory protein in pancreatic ductal adenocarcinoma.
Kim HS; Kim GY; Lim SJ; Kim YW
Pathology; 2010 Dec; 42(7):655-60. PubMed ID: 21080875
[TBL] [Abstract][Full Text] [Related]
3. Clinical and prognostic significance of Raf kinase inhibitory protein expression in gastrointestinal stromal tumors.
Wang Y; Chen JJ; Wang XF; Wang Q
World J Gastroenterol; 2018 Jun; 24(23):2508-2517. PubMed ID: 29930472
[TBL] [Abstract][Full Text] [Related]
4. Raf kinase inhibitor protein combined with phosphorylated extracellular signal-regulated kinase offers valuable prognosis in gastrointestinal stromal tumor.
Qu WZ; Wang L; Chen JJ; Wang Y
World J Gastroenterol; 2023 Jul; 29(26):4200-4213. PubMed ID: 37475847
[TBL] [Abstract][Full Text] [Related]
5. Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients.
Al-Mulla F; Hagan S; Behbehani AI; Bitar MS; George SS; Going JJ; García JJ; Scott L; Fyfe N; Murray GI; Kolch W
J Clin Oncol; 2006 Dec; 24(36):5672-9. PubMed ID: 17179102
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of raf kinase inhibitor protein in esophageal squamous cell carcinoma.
Gao C; Pang L; Ren C; Ma T
Pathol Oncol Res; 2012 Apr; 18(2):471-7. PubMed ID: 22102006
[TBL] [Abstract][Full Text] [Related]
7. Absence of RKIP expression is an independent prognostic biomarker for gastric cancer patients.
Martinho O; Simões K; Longatto-Filho A; Jacob CE; Zilberstein B; Bresciani C; Gama-Rodrigues J; Cecconello I; Alves V; Reis RM
Oncol Rep; 2013 Feb; 29(2):690-6. PubMed ID: 23232914
[TBL] [Abstract][Full Text] [Related]
8. Raf kinase inhibitory protein role in the molecular subtyping of breast cancer.
Al-Mulla F; Marafie M; Zea Tan T; Paul Thiery J
J Cell Biochem; 2014 Mar; 115(3):488-97. PubMed ID: 24123286
[TBL] [Abstract][Full Text] [Related]
9. Expression of Raf-1 kinase inhibitory protein in carcinoma of the ampulla of Vater.
Kim HS; Lee SH; Won KY; Kim GY; Park YK; Kim YW
Virchows Arch; 2012 Jan; 460(1):61-8. PubMed ID: 22102065
[TBL] [Abstract][Full Text] [Related]
10. Reduced expression of Raf-1 kinase inhibitory protein in renal cell carcinoma: a significant prognostic marker.
Moon A; Park JY; Sung JY; Park YK; Kim YW
Pathology; 2012 Oct; 44(6):534-9. PubMed ID: 22935977
[TBL] [Abstract][Full Text] [Related]
11. Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis.
Hagan S; Al-Mulla F; Mallon E; Oien K; Ferrier R; Gusterson B; García JJ; Kolch W
Clin Cancer Res; 2005 Oct; 11(20):7392-7. PubMed ID: 16243812
[TBL] [Abstract][Full Text] [Related]
12. Inverse association between Bmi-1 and RKIP affecting clinical outcome of gastric cancer and revealing the potential molecular mechanisms underlying tumor metastasis and chemotherapy resistance.
Chen Y; Lian G; Ou G; Yang K; Chen J; Li H; Chen S; Li J; Zeng L; Huang K
Gastric Cancer; 2016 Apr; 19(2):392-402. PubMed ID: 25764514
[TBL] [Abstract][Full Text] [Related]
13. Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer.
Fu Z; Kitagawa Y; Shen R; Shah R; Mehra R; Rhodes D; Keller PJ; Mizokami A; Dunn R; Chinnaiyan AM; Yao Z; Keller ET
Prostate; 2006 Feb; 66(3):248-56. PubMed ID: 16175585
[TBL] [Abstract][Full Text] [Related]
14. Effects of Raf kinase inhibitor protein expression on pancreatic cancer cell growth and motility: an in vivo and in vitro study.
Dai H; Chen H; Liu W; You Y; Tan J; Yang A; Lai X; Bie P
J Cancer Res Clin Oncol; 2016 Oct; 142(10):2107-17. PubMed ID: 27444299
[TBL] [Abstract][Full Text] [Related]
15. Association between raf kinase inhibitor protein loss and prognosis in cancers of the digestive system: a meta-analysis.
Yu M; Wang Q; Ding JW; Yang Z; Xie C; Lu NH
Cancer Biomark; 2014; 14(5):389-400. PubMed ID: 25171481
[TBL] [Abstract][Full Text] [Related]
16. High expression of TROP2 correlates with poor prognosis in pancreatic cancer.
Fong D; Moser P; Krammel C; Gostner JM; Margreiter R; Mitterer M; Gastl G; Spizzo G
Br J Cancer; 2008 Oct; 99(8):1290-5. PubMed ID: 18813308
[TBL] [Abstract][Full Text] [Related]
17. Reduced Raf-1 kinase inhibitor protein expression predicts less favorable outcomes in patients with hepatic colorectal metastasis.
Kim HS; Park SJ; Lee KY; Park YK; Kim YW
Oncol Rep; 2012 Jul; 28(1):161-71. PubMed ID: 22562283
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of RKIP and p-ERK in gastric cancer.
Fujimori Y; Inokuchi M; Takagi Y; Kato K; Kojima K; Sugihara K
J Exp Clin Cancer Res; 2012 Mar; 31(1):30. PubMed ID: 22463874
[TBL] [Abstract][Full Text] [Related]
19. RAF-kinase inhibitor protein (RKIP) downregulation in esophageal cancer and its metastases.
Birner P; Jesch B; Schultheis A; Schoppmann SF
Clin Exp Metastasis; 2012 Aug; 29(6):551-9. PubMed ID: 22460832
[TBL] [Abstract][Full Text] [Related]
20. [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma].
Wang Y; Yang J; Gao Y; Zhao XL; Li HZ; Yao Z
Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):522-8. PubMed ID: 19957553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
